Richard Mulligan sold $1.2M of SANA
director at Sana Biotechnology, Inc.. 300,000 shares at an average of $3.99, traded Sep 24, 2024, filed Sep 26, 2024.
Score components
- +15RoleDirector
- +25Trade size$1.2M at market
- +5Share of holdings soldSold 10% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -11.9%, 3m -60.2%, 6m -56.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001562180-24-006954, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 24, 2024 | SOpen-market sale Common Stock10b5-1 | -150,000 | $4.08 | $613k | 2,848,121 | Sep 26, 2024 |
| Sep 25, 2024 | SOpen-market sale Common Stock10b5-1 | -150,000 | $3.89 | $583k | 2,698,121 | Sep 26, 2024 |
Related signals
Other insiders at Sana Biotechnology, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 37Weak | SANAsell Sana Biotechnology, Inc. | Fmr LLC owner, other | $1.9M 290,912 shares | -6% | |
| 33Weak | SANAsell Sana Biotechnology, Inc. | Patrick Y Yang director | $236k 25,000 shares | -14% | |
| 54Moderate | Sana Biotechnology, Inc. | ARCH Venture Fund X, L.P. owner | $10.0M 1,818,181 shares | +18% | |
| 54Moderate | Sana Biotechnology, Inc. | Keith Crandell owner | $10.0M 1,818,181 shares | +18% | |
| 62Notable | Sana Biotechnology, Inc. | Robert Nelsen director, owner | $10.0M 1,818,181 shares | +18% | |
| 9Weak | Sana Biotechnology, Inc. | Christian Hordo EVP, Chief Business Officer | $300k 75,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.